银催化下三氟甲基取代的2-咪唑啉化合物的合成

探索了银盐催化下,三氟甲基酰腙与异氰基乙酸乙酯的[3+2]环加成反应,合成了一系列三氟甲基取代的2-咪唑啉化合物.该方法具有反应速度快、产率高和立体选择性好等特点,为合成三氟甲基取代的2-咪唑啉类化合物提供了一种快速有效的新方法．     

多组份一锅法合成新型2-取代噻唑-4-甲酸衍生物

以甲醇为溶剂,以醛、胺、硫代乙酸和3-(二甲氨基)-2-异氰基丙烯酸甲酯为原料,经四组份一锅法反应合成了9个新型的2-取代噻唑-4-甲酸衍生物,产率25%~54%,纯度90.3%~100%,其结构经1H NMR,13C NMR和LC-MS表征。     

2-硝基-1H-咪唑甲酸乙酯衍生物的合成

2-硝基咪唑是一种重要的医药中间体,可用于合成多种抗癌药物,通过对其结构进行修饰,有望开发新型活性药物分子。以2-氨基嘧啶和3-溴丙酮酸乙酯为起始原料,经过缩合环化、肼解、氧化和取代合成了一系列1-烷基-2-硝基-1H-咪唑-5-甲酸乙酯(7a～7d)及其同分异构体1-烷基-2-硝基-1H-咪唑-4-甲酸乙酯(8a～8d),该方法克服了传统合成路线中氮原子上取代基仅为甲基的局限性。研究不同取代基对2种异构体比例的影响,结果表明：随着取代基团的给电子能力增强,更加有利于化合物7的生成。所有合成化合物的结构都经过¹H NMR,¹³C NMR和MS(ESI)确证或表征。     

银促进的磷自由基与异腈的加成环化反应

以银盐为氧化剂,简单高效地实现了磷自由基对2-异氰基-1,1'-联苯类底物的加成环化反应.该反应原子经济性高、反应体系温和、底物适用范围广、产率高.为C—P键的构筑提供了一种新方法,并且合成了一系列6位磷酰化菲啶类的N-P配体化合物.     

三氟化硼乙醚催化合成1-(氨基甲酰基甲基)-2-烃基-3,1-苯并噁嗪类化合物

研究了三氟化硼乙醚(BF₃·OEt₂)催化2-(N-取代氨基甲酰基甲基氨基)苯甲醇与醛的反应,发展了合成取代3,1-苯并噁嗪类化合物的方法,通过该方法合成了一系列新型结构的1-(氨基甲酰基甲基)-2-烃基-3,1-苯并噁嗪类化合物。 对于这类反应BF₃·OEt₂比三甲基氯硅烷(TMSCl)和四氯化锡(SnCl₄)的普适性更广,它能有效催化这类反应,而后二者却不能。 探讨了TMSCl和SnCl₄不能催化2-(N-取代氨基甲酰甲基氨基)苯甲醇与醛反应的原因。     

Mannich反应合成3,6(8)-二取代-2,4-二氢-1,3-苯并(口恶)嗪及其杀菌活性

以取代苯酚、多聚甲醛和取代苯胺为原料,在无催化剂的条件下,通过Mannich缩合反应合成了一系列新型3,6(8)-二取代-2,4-二氢-1,3-苯并(口恶)嗪类化合物.结果表明,取代苯酚和取代苯胺的取代基为供电子基时,合成产物的产率高于吸电子取代基的.产物的结构用1H NMR、13C NMR、IR和MS等进行了表征.初步测试了目标化合物的杀菌活性,部分化合物具有较好的杀菌活性.当浓度为25 mg/L时,化合物4j和4d对菌核病菌的抑制率分别为86.1％和81.5％,化合物4i对灰霉病菌的抑制率为81.6％.     

Mannich反应合成3,6(8)-二取代-2,4-二氢-1,3-苯并噁嗪及其杀菌活性

以取代苯酚、多聚甲醛和取代苯胺为原料,在无催化剂的条件下,通过Mannich缩合反应合成了一系列新型3,6(8)-二取代-2,4-二氢-1,3-苯并噁嗪类化合物。 结果表明,取代苯酚和取代苯胺的取代基为供电子基时,合成产物的产率高于吸电子取代基的。 产物的结构用1H NMR、13C NMR、IR和MS等进行了表征。 初步测试了目标化合物的杀菌活性,部分化合物具有较好的杀菌活性。 当浓度为25 mg/L时,化合物4j和4d对菌核病菌的抑制率分别为86.1％和81.5％,化合物4i对灰霉病菌的抑制率为81.6％。     

1,3-二芳基-1丙酮类化合物的合成

以取代苯乙酮和取代芳香醛为原料,制得一系列1,3-二芳基-1-氧代丙烯类化合物(1a~1j); 1a~1j和对甲苯磺酰肼(2)经还原反应合成了10个1,3-二苯基-1-丙酮类化合物(3a~3j, 3h为新化合物),其结构经¹H NMR, ¹³C NMR, IR和HR-MS（ESI）确证。研究了碱、溶剂、温度和投料比γ[n(1a)/n(2)/n(碱)]对3a产率的影响。结果表明：γ=1/2/2,磷酸钾为碱,乙醇为溶剂,于80 ℃反应4 h, 3a产率最高（80%）。     

无过渡金属参与下茚并-[1,2-b]吲哚-10(5H)-酮的合成

发展了一种从3-(2-溴代苯甲酰基)-吲哚出发在无过渡金属参与下合成茚并吲哚酮类化合物的新方法。在甲苯/四氢呋喃(2∶1)混合溶剂中,3-(2-溴代苯甲酰基)-吲哚、正丁基锂和碘化锌原位生成的2-吲哚锌在碘化锂辅助下与芳基溴化物发生分子内加成-环化反应,合成了一系列取代的茚并-[1,2-b]吲哚-10(5H)-酮类化合物,且均获得了较好的收率。考察了溶剂、卤化锌、添加剂对产率的影响。     

新型杯[6]芳烃活化KOH催化合成(Z)-1,2-二芳硒基烯

以对叔丁基苯酚为原料，经一步法制得对叔丁基杯[6]芳烃。通过逆傅克反应、亲核取代反应制得二烷基化杯[6]芳烃。最后通过磺化、亲核取代等反应，合成了下缘含喹啉基长链的新型夹状醚杯[6]芳烃化合物（2a~2c），其结构经¹H NMR, ¹³C NMR和HR-MS(ESI-QTOF)表征。以10.0 mol%杯[6]芳烃化合物（2b)为相转移催化剂，20.0 mol%KOH为催化剂，THF为溶剂，较高产率和高选择性地合成了一系列(Z)-1,2-二芳硒基烯化合物，其结构经¹H NMR和NOESY确证。2b重复使用6次，催化活性无明显降低。     

新型芳基修饰的藤黄酸衍生物的合成及其抗肿瘤活性

以取代酚或羟基吡啶为原料,在无水碳酸钾存在下,与溴代醇发生威廉姆森醚合反应制得中间体--芳（杂环）氧基醇(2a~2k); 2a~2k分别与藤黄酸通过光延反应合成了藤黄酸衍生物（3a~3k）。以DDC/HOSu为偶联剂,芳酸与3-氨基-1-丙醇经偶联反应制得中间体--芳酰氨基醇（5a~5h）; 5a~5h分别与藤黄酸通过光延反应合成了藤黄酸衍生物（6a~6h）。 2, 3, 5和6为新化合物,其结构经¹H NMR, ESI-MS和HR-MS表征。采用MTT法测定了3和6对肺腺癌细胞(A549)、肝癌细胞(HepG-2)和乳腺癌细胞(SK-BR-3)的体外抗肿瘤活性。结果表明：部分化合物对肿瘤细胞的抑制活性明显高于藤黄酸。     

2, 6-二甲氧基-2-嘧啶氧基-N-芳基苄胺衍生物的酸催化Smiles重排反应动力学

研究了酸催化下的2, 6-二甲氧基-2-嘧啶氧基-N-芳基苄胺衍生物Smiles重排反应的动力学,考察了盐酸的初始浓度、溶剂、反应温度和取代基对反应速率的影响。结果表明,盐酸的初始浓度增加,重排反应速率加快;在单一溶剂中反应速率的顺序为:甲醇>乙醇>二甲基亚砜>乙腈,而在甲醇/水(1:1, V/V)的混合溶剂中反应速率明显增加,其表观反应速率常数(k_obs)值是甲醇溶剂中的5.27倍;在25-45 ℃温度范围内,各衍生物的反应速率随着温度的升高而加快,其活化能(73.99-76.92 kJ·mol^-1)、活化焓(71.57-74.38 kJ·mol^-1)及Gibbs自由能(81.51-85.77 kJ·mol^-1)数值相近,仅活化熵(-24.38 --47.11 J·K^-1·mol^-1)有一定的差别;取代基常数和表观速率常数之间呈现一定的线性关系,环上吸电子基团的存在有利于反应速率的提高;实验验证了反应机理的合理性。     

由α-氰基肉桂酸乙酯/N-溴代苯甲酰胺合成2-噁唑啉衍生物

作为重要的杂环化合物,合成新的2-噁唑啉衍生物以及发展其新的合成方法具有重要意义,为此以α-氰基肉桂酸乙酯衍生物为底物,以N-溴苯甲酰胺为反应试剂,在无水碳酸钠(相对于底物3为110%摩尔分数)促进下,在丙酮溶剂中,室温下,建立了合成相应2-噁唑啉衍生物的新方法,共合成了11个新化合物,其结构由核磁共振波谱仪(~1H NMR,~(13)C NMR)和高分辨质谱(HRMS)确认。结果显示,各种α-氰基肉桂酸乙酯衍生物(3a~3k)可被顺利的转化成相应的2-噁唑啉衍生物(5a~5k)。在室温下,丙酮作溶剂,以Na_2CO_3为促进剂时,相应产物的最高收率可达90%。不仅α-氰基肉桂酸乙酯衍生物(3)可被用作该反应的底物,而且α-乙氧甲酰基肉桂酸乙酯(6)也适用于该反应。实验结果还证明,除了N-溴代苯甲酰胺外,N-溴代对硝基苯甲酰胺(8)及N-溴代乙酰胺(9)也适用该反应,证明该方法具有广泛的适应性。根据实验结果,提出了可能的反应机理,该机理支持了形成2-噁唑啉衍生物的区域选择性。     

Electron transfer of quinone self-assembled monolayers on a gold electrode

Dialkyl disulfide-linked naphthoquinone, (NQ-C_n-S)₂, and anthraquinone, (AQ-C_n-S)₂, derivatives with different spacer alkyl chains (C_n: n = 2, 6, 12) were synthesized and these quinone derivatives were self-assembled on a gold electrode. The formation of self-assembled monolayers (SAMs) of these derivatives on a gold electrode was confirmed by infrared reflection-absorption spectroscopy (IR-RAS). Electron transfer between the derivatives and the gold electrode was studied by cyclic voltammetry. On the cyclic voltammogram a reversible redox reaction between quinone (Q) and hydroquinone (QH₂) was clearly observed under an aqueous condition. The formal potentials for NQ and AQ derivatives were −0.48 and −0.58 V, respectively, that did not depend on the spacer length. The oxidation and reduction peak currents were strongly dependent on the spacer alkyl chain length. The redox behavior of quinone derivatives depended on the pH condition of the buffer solution. The pH dependence was in agreement with a theoretical value of E_1/2 (mV) = E′ − 59pH for 2H⁺/2e⁻ process in the pH range 3–11. In the range higher than pH 11, the value was estimated with E_1/2 (mV) = E′ − 30pH , which may correspond to H⁺/2e⁻ process. The tunneling barrier coefficients (β) for NQ and AQ SAMs were determined to be 0.12 and 0.73 per methylene group (CH₂), respectively. Comparison of the structures and the alkyl chain length of quinones derivatives on these electron transfers on the electrode is made.     

新型GPR40激动剂的合成及其生物活性

以丁炔二醇为起始原料,用叔丁基二甲基氯硅烷进行单保护后,与2-(6-羟基-2,3-二氢苯并呋喃)乙酸甲酯经Mitsunobu反应制得2-{6-［4-(叔丁基二甲硅烷氧基)丁-2炔基氧基］-2,3-二氢苯并呋喃}乙酸甲酯(3); 3脱除保护后与苯酚衍生物发生Mitsunobu反应,随后经水解合成了6个结构新颖的苯并二氢呋喃衍生物(7a~7f),其结构经¹H NMR, ¹³C NMR和HR-EI-MS表征。GPR40激动活性测试结果表明：7a~7f对GPR40均有激动作用,其中7e和7f激动活性最强,EC₅₀分别为0.593 μmol·L^-1和0.596 μmol·L^-1。     

Synthesis of carpachromene and related isopentenylated derivatives of apigenin

Acacetin (4) on reaction with prenyl bromide in the presence of methanolic sodium methoxide yielded 6,8-di-C-prenyl-(5) and 6-C-prenyl-(10) derivatives. The former (5) formed the corresponding bisdihydropyrano derivative (8). Monomethyl derivative of 10 (12) gave monodihydropyrano derivative (13). DDQ reaction of 10 followed by methylation afforded di-O-methyl carpachromene (2); whereas that of 5 gave a mixture of 21 and 22.

Nuclear prenylation of apigenin (3) in a similar way gave 6,8-di-C-C-prenyl-(16), its 7-0-prenyl-(15) and 6-C-prenyl-(18) derivatives. DDQ reaction of 18 provided natural carpachromene.¹ The structure of the isopentylated apigenin isolated by Dreyer et al.² needs further consideration.     

An Efficient One-pot Synthesis of Certain Stereoselective Spiro[pyrazole-4,5'-isoxazoline]-5-one Derivatives: In vitro Evaluation of Antitumor Activities,Molecular Docking and In silico ADME Predictions

A library of novel spiro[pyrazole-4,5'-isoxazoline]-5-one derivatives were designed and synthesized using a concise and efficient one-pot reaction protocol through 1,3-dipolar cycloaddition between 4-benzylidene-3-methyl-1-phenyl-1H-pyrazol-5(4H)-one and chlorooximes. The synthesized derivatives were elucidated and characterized based on their spectroscopic data, including infrared spectrometry(IR), ¹H NMR, ¹³C NMR, and elemental and mass spectral analysis. The synthesized compounds were evaluated for their antitumor inhibition potency against four human cancer cell lines, including human prostatic adenocarcinoma (PC3), human colorectal carcinoma(HCT116), human liver hepatocellular carcinoma(HepG2) and breast adenocarcinoma (MCF7). The outcomes were compared with the standard reference drug Doxorubicin. Among the synthesized chlorooximes, compounds 6d and 6e were the most active compounds on all cell lines. The spiro[pyrazole-4,5'-isoxazoline]-5-one derivatives 7a and 7c were active on the HepG2 liver cancer cell line. In comparison, compounds 7f and 7g were moderately active on the MCF7 cell line. The structure-activity relationship was explored for the synthesized compounds. Besides, in silico analysis of physicochemical, adsorption, distribution, metabolism, excretion and toxicity(ADMET) properties were done to determine the potential capacity of drug candidates. Molecular docking study onto the epidermal growth factor(EGF) tyrosine kinase receptor(3POZ) was done for the most active compounds to validate the reliability of in vitro anticancer screenings.     

Thirty years of organometallic aryldiazenido arylazo derivatives

The aryldiazenido ligands provide the fourth member of the isoelectronic series CO, NO⁺, RNC, RN₂⁺ of ligands for transition metal complexes. The first aryldiazenido metal complex was reported in 1964 when p-CH₃OC₆H₄N₂Mo(CO)₂C₅H₅ was prepared by the reaction of NaMo(CO)₃C₅H₅ with p-CH₃OC₆H₄N₂⁺BF₄⁻. This review surveys the development of organometallic aryldiazenido chemistry since that time. Such organometallic aryldiazenido derivatives, including RN₂M(CO)₂C₅H₅, RN₂M(CO)₂(Pz₃BH) (M = Cr, Mo, W), [(η⁶-Me₆C₆)Cr(CO)₂N₂Ar]⁺, [(MeC₁₅H₄)M′(CO)₂N₂Ar]⁺ M′ = Mn, Re), [trans-PhN₂Fe(CO)₂(PPh₃)₂]⁺, and PhN₂M′(CO)₂(PPh₃)₂(PPh₃)₂ can be obtained by reactions of arenediazonium salts with suitably chosen transition metal nucleophiles. Analogous methods cannot be used to prepare alkyldiazenido transition metal complexes because of the instability of alkyldiazonium salts. However, the alkyldiazenido derivatives RCH₂N₂M(CO)₂C₅H₅ (R = H or Me₃Si) can be obtained from HM(CO)₃C₅H₅ and the corresponding diazoalkanes. Important aspects of the chemical reactivity of RN₂M(CO)₂Q derivatives (Q = C₅H₅, Pz₃BH) include CO substitution reactions, coordination of the second nitrogen in the RN₂ ligand to give heterobimetallic complexes such as C₅H₅Mo(CO)₂(μ-NNC₆H₄Me)(CO)₂C₅H₅, oxidative addition rections with X₂ X = Cl, Br, I), SnX₄, RSSR, and CINO, and reactions with further RN₂⁺ to give bis(aryldiazenido) derivatives (RN₂)₂MQL⁺ (L = CO, X⁻, etc.). Dearylation of an aryldiazenido ligand to a dinitrogen ligand can be effected by reaction of [(MeC₅H₄)M′(CO)₂N₂Ar]⁺ with certain nucleophiles to give (MeC₅H₄)M′(CO)₂N₂.     

An answer to the spiro versus ANSA dilemma in cyclophosphazenes : Part IX. The first genuine ANSA derivatives from N3P3Cl6 itself

The reaction of the simplest Lehn's ligand, H₂N---(CH₂)₂---O---(CH₂)₂---NH₂, on N₃P₃Cl₆ in suitable stoichiometric conditions leads quite neatly to the first genuine MONOANSA and DIANSA derivatives.     

β-硝基苯乙烯衍生物与二溴海因高度区域选择性氨溴加成反应

以β-硝基苯乙烯衍生物为底物, 二溴海因为氮源/卤素源, 乙腈作溶剂, 建立了碳碳双键上高度区域选择性氨溴加成反应新体系. β-硝基苯乙烯衍生物与二溴海因在室温无水碳酸钠催化下反应, 可高收率获得邻位氨溴加成产物, 最高收率达97%; β-甲基-β-硝基苯乙烯衍生物在氢氧化钾催化下回流反应, 也可高收率得到邻位氨溴加成产物, 最高收率达95%. 实验结果表明, 对于硝基苯乙烯衍生物, 当苯环4-位具有强供电子基团如CH₃O时, 可以得到单一的α-氨基-β-溴加成产物, 但其收率相对较低; 当硝基苯乙烯衍生物的苯环4-位有强吸电子基团如NO₂时, 反应收率则很高. 这一实验结果证明β-硝基苯乙烯衍生物(缺电子烯烃)与二溴海因的氨溴加成反应具有亲核加成的特征. 本文共考察了20种不同结构的β-硝基苯乙烯衍生物的氨溴加成反应情况, 其产物结构经核磁共振波谱及质谱分析确证, 并提出了可能的反应机理.